Clinical Trials · NCT02455076
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Emory University
- Enrollment
- 150
- Start date
- Sep 2015
- Locations
- 2 sites, United States
- Primary endpoint
- Mean Daily Blood Glucose Concentration Inpatient